Zhong-yuan F. Xia
99 Zi Yang Road
Wuhan, 430060, China
Wuhan, 430060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Hyperglycemia-induced SIRT3 inhibition contributes to diabetic cardiomyopathy by impairing Cav-3-mediated mitophagy.
Journal: Biochemical pharmacology
Published: December 04, 2025
Effect of liposomal bupivacaine for preoperative erector spinae plane block on postoperative pain following video-assisted thoracoscopic lung resection: a multicenter, randomized, double-blind, clinical trial.
Journal: International journal of surgery (London, England)
Published: June 06, 2025
Necroptosis: a significant and promising target for intervention of cardiovascular disease.
Journal: Biochemical pharmacology
Published: December 20, 2024
Caveolin-3: therapeutic target for diabetic myocardial ischemia/reperfusion injury.
Journal: Molecular medicine (Cambridge, Mass.)
Published: November 07, 2024
DJ-1: Potential target for treatment of myocardial ischemia-reperfusion injury.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 21, 2024
Nobiletin alleviates myocardial ischemia-reperfusion injury via ferroptosis in rats with type-2 diabetes mellitus.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 03, 2023
The role of circadian clock-controlled mitochondrial dynamics in diabetic cardiomyopathy.
Journal: Frontiers in immunology
Published: January 11, 2023
Intravenous Administration of Hypertonic Glucose Solution to Prevent Dizziness in Patients Undergoing Gastrointestinal Endoscopy Under General Anesthesia: A Randomized Clinical Trial.
Journal: Combinatorial chemistry & high throughput screening
Published: August 15, 2022
Rev-erbs agonist SR9009 alleviates ischemia-reperfusion injury by heightening endogenous cardioprotection at onset of type-2 diabetes in rats: Down-regulating ferritinophagy/ferroptosis signaling.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 20, 2022
Shenmai Injection Attenuates Myocardial Ischemia/Reperfusion Injury by Targeting Nrf2/GPX4 Signalling-Mediated Ferroptosis.
Journal: Chinese journal of integrative medicine
Published: June 24, 2022
Role of CK1ε-regulated PERIOD2 in STZ-induced diabetic myocardial injury.
Journal: Frontiers in bioscience (Landmark edition)
Published: November 03, 2021
Last Updated: 09/26/2026